CATABASIS PHARMACEUTICALS IN - COM (CATB)

CUSIP: 14875P107

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
29,270,528
Share change
+21,488,402
Total reported value
$28,069,000
Price per share
$0.96
Number of holders
30
Value change
+$20,573,470
Number of buys
19
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 14875P107?
CUSIP 14875P107 identifies CATB - CATABASIS PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM (CATB) as of Q2 2018

As of 30 Jun 2018, CATABASIS PHARMACEUTICALS IN - COM (CATB) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,270,528 shares. The largest 10 holders included FEDERATED INVESTORS INC /PA/, SV Health Investors, LLC, CVI Holdings, LLC, VANGUARD GROUP INC, Stonepine Capital Management, LLC, Clarus Ventures, LLC, ARMISTICE CAPITAL, LLC, Alyeska Investment Group, L.P., RENAISSANCE TECHNOLOGIES LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 30 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.